BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioAdaptives's shares outstanding was 281M at Jun 30, 2026. For fiscal 2025 it was 10M, up 22.6% from the year before. The highest annual figure on record is 20M in fiscal 2020.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10M | +22.6% |
| FY2024 | Dec 31, 2024 | 8M | +37.6% |
| FY2023 | Dec 31, 2023 | 6M | -70.7% |
| FY2020 | Dec 31, 2020 | 20M | +9.3% |
| FY2019 | Dec 31, 2019 | 19M | +9.9% |
| FY2018 | Dec 31, 2018 | 17M | +33.4% |
| FY2015 | Dec 31, 2015 | 13M | +2.0% |
| FY2014 | Dec 31, 2014 | 12M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 281M | +2849.6% |
| Q1 FY2026 | Mar 31, 2026 | 12M | +32.7% |
| Q4 FY2025 | Dec 31, 2025 | 12M | +21.4% |
| Q3 FY2025 | Sep 30, 2025 | 10M | +24.7% |
| Q2 FY2025 | Jun 30, 2025 | 10M | +219.3% |
| Q1 FY2025 | Mar 31, 2025 | 9M | +17.5% |
| Q4 FY2024 | Dec 31, 2024 | 10M | -98.6% |
| Q3 FY2024 | Sep 30, 2024 | 8M | -75.7% |
| Q2 FY2024 | Jun 30, 2024 | 3M | -91.0% |
| Q1 FY2024 | Mar 31, 2024 | 8M | -72.7% |
| Q3 FY2023 | Sep 30, 2023 | 730M | +3429.4% |
| Q3 FY2021 | Sep 30, 2021 | 34M | +62.6% |
| Q2 FY2021 | Jun 30, 2021 | 33M | +66.6% |
| Q1 FY2021 | Mar 31, 2021 | 28M | +48.6% |
| Q4 FY2020 | Dec 31, 2020 | 21M | +9.5% |
| Q3 FY2020 | Sep 30, 2020 | 21M | +11.1% |
| Q2 FY2020 | Jun 30, 2020 | 20M | +6.8% |
| Q1 FY2020 | Mar 31, 2020 | 19M | -16.3% |
| Q4 FY2019 | Dec 31, 2019 | 19M | +3.5% |
| Q3 FY2019 | Sep 30, 2019 | 19M | +13.0% |
| Q2 FY2019 | Jun 30, 2019 | 19M | +10.0% |
| Q1 FY2019 | Mar 31, 2019 | 23M | +59.5% |
| Q4 FY2018 | Dec 31, 2018 | 18M | +28.7% |
| Q3 FY2018 | Sep 30, 2018 | 17M | +23.0% |
| Q2 FY2018 | Jun 30, 2018 | 17M | +32.5% |
| Q3 FY2016 | Sep 30, 2016 | 14M | +11.3% |
| Q2 FY2016 | Jun 30, 2016 | 14M | – |
| Q1 FY2016 | Mar 31, 2016 | 13M | – |
| Q4 FY2015 | Dec 31, 2015 | 13M | – |
| Q3 FY2015 | Sep 30, 2015 | 13M | – |
See a number that looks wrong?